- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Immunoinformatics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Immunoinformatics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Allergy Prediction Databases accounting for % of the Immunoinformatics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cancer Diagnosis & Therapy segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Immunoinformatics include EpiVax, Novozymes Biopharma, ioGenetics, International Society of Vaccines, and IMGT, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Immunoinformatics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cancer Diagnosis & Therapy
Reverse Vaccinology
Immune System Modeling
Market segment by Application, can be divided into
Allergy Prediction Databases
Analysis Resource Database
International Immunogenetics System
The Ontology of Immune Epitopes
Immune Epitope Database
Market segment by players, this report covers
EpiVax
Novozymes Biopharma
ioGenetics
International Society of Vaccines
IMGT
Dassault Systemes
Certara
Chemical Computing Group
Compugen
Genedata AG
Insilico Biotechnology AG
Leadscope Inc
Nimbus Discovery
Strand Life Sciences
Schrodinger
Simulation Plus
Rosa & Co
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Immunoinformatics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Immunoinformatics, with revenue, gross margin and global market share of Immunoinformatics from 2019 to 2022.
Chapter 3, the Immunoinformatics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Immunoinformatics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Immunoinformatics research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Immunoinformatics
1.2 Classification of Immunoinformatics by Type
1.2.1 Overview: Global Immunoinformatics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Immunoinformatics Revenue Market Share by Type in 2021
1.2.3 Cancer Diagnosis & Therapy
1.2.4 Reverse Vaccinology
1.2.5 Immune System Modeling
1.3 Global Immunoinformatics Market by Application
1.3.1 Overview: Global Immunoinformatics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Allergy Prediction Databases
1.3.3 Analysis Resource Database
1.3.4 International Immunogenetics System
1.3.5 The Ontology of Immune Epitopes
1.3.6 Immune Epitope Database
1.4 Global Immunoinformatics Market Size & Forecast
1.5 Global Immunoinformatics Market Size and Forecast by Region
1.5.1 Global Immunoinformatics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Immunoinformatics Market Size by Region, (2017-2022)
1.5.3 North America Immunoinformatics Market Size and Prospect (2017-2028)
1.5.4 Europe Immunoinformatics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Immunoinformatics Market Size and Prospect (2017-2028)
1.5.6 South America Immunoinformatics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Immunoinformatics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Immunoinformatics Market Drivers
1.6.2 Immunoinformatics Market Restraints
1.6.3 Immunoinformatics Trends Analysis
2 Company Profiles
2.1 EpiVax
2.1.1 EpiVax Details
2.1.2 EpiVax Major Business
2.1.3 EpiVax Immunoinformatics Product and Solutions
2.1.4 EpiVax Immunoinformatics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 EpiVax Recent Developments and Future Plans
2.2 Novozymes Biopharma
2.2.1 Novozymes Biopharma Details
2.2.2 Novozymes Biopharma Major Business
2.2.3 Novozymes Biopharma Immunoinformatics Product and Solutions
2.2.4 Novozymes Biopharma Immunoinformatics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Novozymes Biopharma Recent Developments and Future Plans
2.3 ioGenetics
2.3.1 ioGenetics Details
2.3.2 ioGenetics Major Business
2.3.3 ioGenetics Immunoinformatics Product and Solutions
2.3.4 ioGenetics Immunoinformatics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 ioGenetics Recent Developments and Future Plans
2.4 International Society of Vaccines
2.4.1 International Society of Vaccines Details
2.4.2 International Society of Vaccines Major Business
2.4.3 International Society of Vaccines Immunoinformatics Product and Solutions
2.4.4 International Society of Vaccines Immunoinformatics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 International Society of Vaccines Recent Developments and Future Plans
2.5 IMGT
2.5.1 IMGT Details
2.5.2 IMGT Major Business
2.5.3 IMGT Immunoinformatics Product and Solutions
2.5.4 IMGT Immunoinformatics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 IMGT Recent Developments and Future Plans
2.6 Dassault Systemes
2.6.1 Dassault Systemes Details
2.6.2 Dassault Systemes Major Business
2.6.3 Dassault Systemes Immunoinformatics Product and Solutions
2.6.4 Dassault Systemes Immunoinformatics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Dassault Systemes Recent Developments and Future Plans
2.7 Certara
2.7.1 Certara Details
2.7.2 Certara Major Business
2.7.3 Certara Immunoinformatics Product and Solutions
2.7.4 Certara Immunoinformatics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Certara Recent Developments and Future Plans
2.8 Chemical Computing Group
2.8.1 Chemical Computing Group Details
2.8.2 Chemical Computing Group Major Business
2.8.3 Chemical Computing Group Immunoinformatics Product and Solutions
2.8.4 Chemical Computing Group Immunoinformatics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Chemical Computing Group Recent Developments and Future Plans
2.9 Compugen
2.9.1 Compugen Details
2.9.2 Compugen Major Business
2.9.3 Compugen Immunoinformatics Product and Solutions
2.9.4 Compugen Immunoinformatics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Compugen Recent Developments and Future Plans
2.10 Genedata AG
2.10.1 Genedata AG Details
2.10.2 Genedata AG Major Business
2.10.3 Genedata AG Immunoinformatics Product and Solutions
2.10.4 Genedata AG Immunoinformatics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Genedata AG Recent Developments and Future Plans
2.11 Insilico Biotechnology AG
2.11.1 Insilico Biotechnology AG Details
2.11.2 Insilico Biotechnology AG Major Business
2.11.3 Insilico Biotechnology AG Immunoinformatics Product and Solutions
2.11.4 Insilico Biotechnology AG Immunoinformatics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Insilico Biotechnology AG Recent Developments and Future Plans
2.12 Leadscope Inc
2.12.1 Leadscope Inc Details
2.12.2 Leadscope Inc Major Business
2.12.3 Leadscope Inc Immunoinformatics Product and Solutions
2.12.4 Leadscope Inc Immunoinformatics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Leadscope Inc Recent Developments and Future Plans
2.13 Nimbus Discovery
2.13.1 Nimbus Discovery Details
2.13.2 Nimbus Discovery Major Business
2.13.3 Nimbus Discovery Immunoinformatics Product and Solutions
2.13.4 Nimbus Discovery Immunoinformatics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Nimbus Discovery Recent Developments and Future Plans
2.14 Strand Life Sciences
2.14.1 Strand Life Sciences Details
2.14.2 Strand Life Sciences Major Business
2.14.3 Strand Life Sciences Immunoinformatics Product and Solutions
2.14.4 Strand Life Sciences Immunoinformatics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Strand Life Sciences Recent Developments and Future Plans
2.15 Schrodinger
2.15.1 Schrodinger Details
2.15.2 Schrodinger Major Business
2.15.3 Schrodinger Immunoinformatics Product and Solutions
2.15.4 Schrodinger Immunoinformatics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Schrodinger Recent Developments and Future Plans
2.16 Simulation Plus
2.16.1 Simulation Plus Details
2.16.2 Simulation Plus Major Business
2.16.3 Simulation Plus Immunoinformatics Product and Solutions
2.16.4 Simulation Plus Immunoinformatics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Simulation Plus Recent Developments and Future Plans
2.17 Rosa & Co
2.17.1 Rosa & Co Details
2.17.2 Rosa & Co Major Business
2.17.3 Rosa & Co Immunoinformatics Product and Solutions
2.17.4 Rosa & Co Immunoinformatics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Rosa & Co Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Immunoinformatics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Immunoinformatics Players Market Share in 2021
3.2.2 Top 10 Immunoinformatics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Immunoinformatics Players Head Office, Products and Services Provided
3.4 Immunoinformatics Mergers & Acquisitions
3.5 Immunoinformatics New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Immunoinformatics Revenue and Market Share by Type (2017-2022)
4.2 Global Immunoinformatics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Immunoinformatics Revenue Market Share by Application (2017-2022)
5.2 Global Immunoinformatics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Immunoinformatics Revenue by Type (2017-2028)
6.2 North America Immunoinformatics Revenue by Application (2017-2028)
6.3 North America Immunoinformatics Market Size by Country
6.3.1 North America Immunoinformatics Revenue by Country (2017-2028)
6.3.2 United States Immunoinformatics Market Size and Forecast (2017-2028)
6.3.3 Canada Immunoinformatics Market Size and Forecast (2017-2028)
6.3.4 Mexico Immunoinformatics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Immunoinformatics Revenue by Type (2017-2028)
7.2 Europe Immunoinformatics Revenue by Application (2017-2028)
7.3 Europe Immunoinformatics Market Size by Country
7.3.1 Europe Immunoinformatics Revenue by Country (2017-2028)
7.3.2 Germany Immunoinformatics Market Size and Forecast (2017-2028)
7.3.3 France Immunoinformatics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Immunoinformatics Market Size and Forecast (2017-2028)
7.3.5 Russia Immunoinformatics Market Size and Forecast (2017-2028)
7.3.6 Italy Immunoinformatics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Immunoinformatics Revenue by Type (2017-2028)
8.2 Asia-Pacific Immunoinformatics Revenue by Application (2017-2028)
8.3 Asia-Pacific Immunoinformatics Market Size by Region
8.3.1 Asia-Pacific Immunoinformatics Revenue by Region (2017-2028)
8.3.2 China Immunoinformatics Market Size and Forecast (2017-2028)
8.3.3 Japan Immunoinformatics Market Size and Forecast (2017-2028)
8.3.4 South Korea Immunoinformatics Market Size and Forecast (2017-2028)
8.3.5 India Immunoinformatics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Immunoinformatics Market Size and Forecast (2017-2028)
8.3.7 Australia Immunoinformatics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Immunoinformatics Revenue by Type (2017-2028)
9.2 South America Immunoinformatics Revenue by Application (2017-2028)
9.3 South America Immunoinformatics Market Size by Country
9.3.1 South America Immunoinformatics Revenue by Country (2017-2028)
9.3.2 Brazil Immunoinformatics Market Size and Forecast (2017-2028)
9.3.3 Argentina Immunoinformatics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Immunoinformatics Revenue by Type (2017-2028)
10.2 Middle East & Africa Immunoinformatics Revenue by Application (2017-2028)
10.3 Middle East & Africa Immunoinformatics Market Size by Country
10.3.1 Middle East & Africa Immunoinformatics Revenue by Country (2017-2028)
10.3.2 Turkey Immunoinformatics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Immunoinformatics Market Size and Forecast (2017-2028)
10.3.4 UAE Immunoinformatics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Immunoinformatics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Immunoinformatics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Immunoinformatics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Immunoinformatics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Immunoinformatics Revenue Market Share by Region (2023-2028)
Table 6. EpiVax Corporate Information, Head Office, and Major Competitors
Table 7. EpiVax Major Business
Table 8. EpiVax Immunoinformatics Product and Solutions
Table 9. EpiVax Immunoinformatics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Novozymes Biopharma Corporate Information, Head Office, and Major Competitors
Table 11. Novozymes Biopharma Major Business
Table 12. Novozymes Biopharma Immunoinformatics Product and Solutions
Table 13. Novozymes Biopharma Immunoinformatics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. ioGenetics Corporate Information, Head Office, and Major Competitors
Table 15. ioGenetics Major Business
Table 16. ioGenetics Immunoinformatics Product and Solutions
Table 17. ioGenetics Immunoinformatics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. International Society of Vaccines Corporate Information, Head Office, and Major Competitors
Table 19. International Society of Vaccines Major Business
Table 20. International Society of Vaccines Immunoinformatics Product and Solutions
Table 21. International Society of Vaccines Immunoinformatics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. IMGT Corporate Information, Head Office, and Major Competitors
Table 23. IMGT Major Business
Table 24. IMGT Immunoinformatics Product and Solutions
Table 25. IMGT Immunoinformatics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Dassault Systemes Corporate Information, Head Office, and Major Competitors
Table 27. Dassault Systemes Major Business
Table 28. Dassault Systemes Immunoinformatics Product and Solutions
Table 29. Dassault Systemes Immunoinformatics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Certara Corporate Information, Head Office, and Major Competitors
Table 31. Certara Major Business
Table 32. Certara Immunoinformatics Product and Solutions
Table 33. Certara Immunoinformatics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Chemical Computing Group Corporate Information, Head Office, and Major Competitors
Table 35. Chemical Computing Group Major Business
Table 36. Chemical Computing Group Immunoinformatics Product and Solutions
Table 37. Chemical Computing Group Immunoinformatics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Compugen Corporate Information, Head Office, and Major Competitors
Table 39. Compugen Major Business
Table 40. Compugen Immunoinformatics Product and Solutions
Table 41. Compugen Immunoinformatics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Genedata AG Corporate Information, Head Office, and Major Competitors
Table 43. Genedata AG Major Business
Table 44. Genedata AG Immunoinformatics Product and Solutions
Table 45. Genedata AG Immunoinformatics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Insilico Biotechnology AG Corporate Information, Head Office, and Major Competitors
Table 47. Insilico Biotechnology AG Major Business
Table 48. Insilico Biotechnology AG Immunoinformatics Product and Solutions
Table 49. Insilico Biotechnology AG Immunoinformatics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Leadscope Inc Corporate Information, Head Office, and Major Competitors
Table 51. Leadscope Inc Major Business
Table 52. Leadscope Inc Immunoinformatics Product and Solutions
Table 53. Leadscope Inc Immunoinformatics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Nimbus Discovery Corporate Information, Head Office, and Major Competitors
Table 55. Nimbus Discovery Major Business
Table 56. Nimbus Discovery Immunoinformatics Product and Solutions
Table 57. Nimbus Discovery Immunoinformatics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Strand Life Sciences Corporate Information, Head Office, and Major Competitors
Table 59. Strand Life Sciences Major Business
Table 60. Strand Life Sciences Immunoinformatics Product and Solutions
Table 61. Strand Life Sciences Immunoinformatics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Schrodinger Corporate Information, Head Office, and Major Competitors
Table 63. Schrodinger Major Business
Table 64. Schrodinger Immunoinformatics Product and Solutions
Table 65. Schrodinger Immunoinformatics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Simulation Plus Corporate Information, Head Office, and Major Competitors
Table 67. Simulation Plus Major Business
Table 68. Simulation Plus Immunoinformatics Product and Solutions
Table 69. Simulation Plus Immunoinformatics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Rosa & Co Corporate Information, Head Office, and Major Competitors
Table 71. Rosa & Co Major Business
Table 72. Rosa & Co Immunoinformatics Product and Solutions
Table 73. Rosa & Co Immunoinformatics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Global Immunoinformatics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 75. Global Immunoinformatics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 76. Breakdown of Immunoinformatics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 77. Immunoinformatics Players Head Office, Products and Services Provided
Table 78. Immunoinformatics Mergers & Acquisitions in the Past Five Years
Table 79. Immunoinformatics New Entrants and Expansion Plans
Table 80. Global Immunoinformatics Revenue (USD Million) by Type (2017-2022)
Table 81. Global Immunoinformatics Revenue Share by Type (2017-2022)
Table 82. Global Immunoinformatics Revenue Forecast by Type (2023-2028)
Table 83. Global Immunoinformatics Revenue by Application (2017-2022)
Table 84. Global Immunoinformatics Revenue Forecast by Application (2023-2028)
Table 85. North America Immunoinformatics Revenue by Type (2017-2022) & (USD Million)
Table 86. North America Immunoinformatics Revenue by Type (2023-2028) & (USD Million)
Table 87. North America Immunoinformatics Revenue by Application (2017-2022) & (USD Million)
Table 88. North America Immunoinformatics Revenue by Application (2023-2028) & (USD Million)
Table 89. North America Immunoinformatics Revenue by Country (2017-2022) & (USD Million)
Table 90. North America Immunoinformatics Revenue by Country (2023-2028) & (USD Million)
Table 91. Europe Immunoinformatics Revenue by Type (2017-2022) & (USD Million)
Table 92. Europe Immunoinformatics Revenue by Type (2023-2028) & (USD Million)
Table 93. Europe Immunoinformatics Revenue by Application (2017-2022) & (USD Million)
Table 94. Europe Immunoinformatics Revenue by Application (2023-2028) & (USD Million)
Table 95. Europe Immunoinformatics Revenue by Country (2017-2022) & (USD Million)
Table 96. Europe Immunoinformatics Revenue by Country (2023-2028) & (USD Million)
Table 97. Asia-Pacific Immunoinformatics Revenue by Type (2017-2022) & (USD Million)
Table 98. Asia-Pacific Immunoinformatics Revenue by Type (2023-2028) & (USD Million)
Table 99. Asia-Pacific Immunoinformatics Revenue by Application (2017-2022) & (USD Million)
Table 100. Asia-Pacific Immunoinformatics Revenue by Application (2023-2028) & (USD Million)
Table 101. Asia-Pacific Immunoinformatics Revenue by Region (2017-2022) & (USD Million)
Table 102. Asia-Pacific Immunoinformatics Revenue by Region (2023-2028) & (USD Million)
Table 103. South America Immunoinformatics Revenue by Type (2017-2022) & (USD Million)
Table 104. South America Immunoinformatics Revenue by Type (2023-2028) & (USD Million)
Table 105. South America Immunoinformatics Revenue by Application (2017-2022) & (USD Million)
Table 106. South America Immunoinformatics Revenue by Application (2023-2028) & (USD Million)
Table 107. South America Immunoinformatics Revenue by Country (2017-2022) & (USD Million)
Table 108. South America Immunoinformatics Revenue by Country (2023-2028) & (USD Million)
Table 109. Middle East & Africa Immunoinformatics Revenue by Type (2017-2022) & (USD Million)
Table 110. Middle East & Africa Immunoinformatics Revenue by Type (2023-2028) & (USD Million)
Table 111. Middle East & Africa Immunoinformatics Revenue by Application (2017-2022) & (USD Million)
Table 112. Middle East & Africa Immunoinformatics Revenue by Application (2023-2028) & (USD Million)
Table 113. Middle East & Africa Immunoinformatics Revenue by Country (2017-2022) & (USD Million)
Table 114. Middle East & Africa Immunoinformatics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Immunoinformatics Picture
Figure 2. Global Immunoinformatics Revenue Market Share by Type in 2021
Figure 3. Cancer Diagnosis & Therapy
Figure 4. Reverse Vaccinology
Figure 5. Immune System Modeling
Figure 6. Immunoinformatics Revenue Market Share by Application in 2021
Figure 7. Allergy Prediction Databases Picture
Figure 8. Analysis Resource Database Picture
Figure 9. International Immunogenetics System Picture
Figure 10. The Ontology of Immune Epitopes Picture
Figure 11. Immune Epitope Database Picture
Figure 12. Global Immunoinformatics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Immunoinformatics Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Immunoinformatics Revenue Market Share by Region (2017-2028)
Figure 15. Global Immunoinformatics Revenue Market Share by Region in 2021
Figure 16. North America Immunoinformatics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Immunoinformatics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Immunoinformatics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Immunoinformatics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Immunoinformatics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Immunoinformatics Market Drivers
Figure 22. Immunoinformatics Market Restraints
Figure 23. Immunoinformatics Market Trends
Figure 24. EpiVax Recent Developments and Future Plans
Figure 25. Novozymes Biopharma Recent Developments and Future Plans
Figure 26. ioGenetics Recent Developments and Future Plans
Figure 27. International Society of Vaccines Recent Developments and Future Plans
Figure 28. IMGT Recent Developments and Future Plans
Figure 29. Dassault Systemes Recent Developments and Future Plans
Figure 30. Certara Recent Developments and Future Plans
Figure 31. Chemical Computing Group Recent Developments and Future Plans
Figure 32. Compugen Recent Developments and Future Plans
Figure 33. Genedata AG Recent Developments and Future Plans
Figure 34. Insilico Biotechnology AG Recent Developments and Future Plans
Figure 35. Leadscope Inc Recent Developments and Future Plans
Figure 36. Nimbus Discovery Recent Developments and Future Plans
Figure 37. Strand Life Sciences Recent Developments and Future Plans
Figure 38. Schrodinger Recent Developments and Future Plans
Figure 39. Simulation Plus Recent Developments and Future Plans
Figure 40. Rosa & Co Recent Developments and Future Plans
Figure 41. Global Immunoinformatics Revenue Share by Players in 2021
Figure 42. Immunoinformatics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 43. Global Top 3 Players Immunoinformatics Revenue Market Share in 2021
Figure 44. Global Top 10 Players Immunoinformatics Revenue Market Share in 2021
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 46. Global Immunoinformatics Revenue Share by Type in 2021
Figure 47. Global Immunoinformatics Market Share Forecast by Type (2023-2028)
Figure 48. Global Immunoinformatics Revenue Share by Application in 2021
Figure 49. Global Immunoinformatics Market Share Forecast by Application (2023-2028)
Figure 50. North America Immunoinformatics Sales Market Share by Type (2017-2028)
Figure 51. North America Immunoinformatics Sales Market Share by Application (2017-2028)
Figure 52. North America Immunoinformatics Revenue Market Share by Country (2017-2028)
Figure 53. United States Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Canada Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Mexico Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Europe Immunoinformatics Sales Market Share by Type (2017-2028)
Figure 57. Europe Immunoinformatics Sales Market Share by Application (2017-2028)
Figure 58. Europe Immunoinformatics Revenue Market Share by Country (2017-2028)
Figure 59. Germany Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. France Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. United Kingdom Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Russia Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Italy Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Asia-Pacific Immunoinformatics Sales Market Share by Type (2017-2028)
Figure 65. Asia-Pacific Immunoinformatics Sales Market Share by Application (2017-2028)
Figure 66. Asia-Pacific Immunoinformatics Revenue Market Share by Region (2017-2028)
Figure 67. China Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Japan Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South Korea Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. India Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Southeast Asia Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Australia Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. South America Immunoinformatics Sales Market Share by Type (2017-2028)
Figure 74. South America Immunoinformatics Sales Market Share by Application (2017-2028)
Figure 75. South America Immunoinformatics Revenue Market Share by Country (2017-2028)
Figure 76. Brazil Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Argentina Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Middle East and Africa Immunoinformatics Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Immunoinformatics Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Immunoinformatics Revenue Market Share by Country (2017-2028)
Figure 81. Turkey Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Saudi Arabia Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. UAE Immunoinformatics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
